Comparing Risk Scoring Systems Beyond the ROC Paradigm in Survival Analysis

∗Dana Farber Cancer Institute and Harvard University, huno@jimmy.harvard.edu †Stanford University School of Medicine, lutian@stanford.edu ‡Harvard University, tcai@hsph.harvard.edu ∗∗Harvard University and Massachusetts Institute of Technology, isaac.kohane@tch.harvard.edu ††Harvard University, wei@hsph.harvard.edu This working paper is hosted by The Berkeley Electronic Press (bepress) and may not be commercially reproduced without the permission of the copyright holder.

[1]  O. Borgan.  The Statistical Analysis of Failure Time Data (2nd Ed.). John D. Kalbfleisch and Ross L. Prentice , 2003 .

[2]  Daniel B. Mark,et al.  TUTORIAL IN BIOSTATISTICS MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS , 1996 .

[3]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[4]  Hajime Uno,et al.  Calibrating parametric subject-specific risk estimation. , 2010, Biometrika.

[5]  Howard Y. Chang,et al.  Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Changbao Wu,et al.  Jackknife, Bootstrap and Other Resampling Methods in Regression Analysis , 1986 .

[7]  D. Bamber.  The area above the ordinal dominance graph and the area below the receiver operating characteristic graph , 1975 .

[8]  M. Pepe,et al.  Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. , 2004, American journal of epidemiology.

[9]  P. Heagerty,et al.  Survival Model Predictive Accuracy and ROC Curves , 2005, Biometrics.

[10]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[11]  Nils Lid Hjort,et al.  On inference in parametric survival data models , 1992 .

[12]  M. Pencina,et al.  On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data , 2011, Statistics in medicine.

[13]  M. Pencina,et al.  Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation , 2004, Statistics in medicine.

[14]  Z. Ying,et al.  Analysis of transformation models with censored data , 1995 .

[15]  Nancy R Cook,et al.  The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women , 2006, Annals of Internal Medicine.

[16]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[17]  T. Cai,et al.  Robust combination of multiple diagnostic tests for classifying censored event times. , 2007, Biostatistics.

[18]  Van,et al.  A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.

[19]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[20]  J. Ware.  The limitations of risk factors as prognostic tools. , 2006, The New England journal of medicine.

[21]  P. Greenland,et al.  When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk. , 2005, Archives of internal medicine.

[22]  D.,et al.  Regression Models and Life-Tables , 2022 .

[23]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[24]  Anastasios A. Tsiatis,et al.  Estimating medical costs with censored data , 2000 .

[25]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[26]  D. Pollard.  Empirical Processes: Theory and Applications , 1990 .